A 26-week carcinogenicity study of 2-amino-3-methylimidazo[4,5-f]quinoline in rasH2 mice

Toxicologic Pathology

Volumn 34, Issue 2, 2006, Pages 199-205

  Okamura, Miwa ^a,b   Moto, Mitsuyoshi ^a,b   Muguruma, Masako ^a   Ito, Tadashi ^a,b   Jin, Meilan ^a   Kashida, Yoko ^a   Mitsumori, Kunitoshi ^a  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^b GIFU UNIVERSITY   (Japan)

Author keywords

Carcinogenicity; Forestomach; Heterocyclic amine; IQ; RasH2 mice; Transgenic mice

Indexed keywords

2 AMINO 3 METHYLIMIDAZO[4,5 F]QUINOLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGEN TESTING; CARCINOGENICITY; CARCINOMA; CELL HYPERPLASIA; CELL PROLIFERATION; CONTROLLED STUDY; FEEDING; FEMALE; FORESTOMACH; HISTOPATHOLOGY; HYPERTROPHY; LIVER; LIVER CELL DAMAGE; MALE; MICROSCOPY; MOUSE; NONHUMAN; PAPILLOMA; PRIORITY JOURNAL; SQUAMOUS CELL; STOMACH LESION; WILD TYPE;

ANIMALS; CARCINOGENICITY TESTS; CARCINOGENS; CARCINOMA, HEPATOCELLULAR; DISEASE SUSCEPTIBILITY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RAS; HYPERPLASIA; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, TRANSGENIC; NEOPLASMS; PAPILLOMA; QUINOLINES; STOMACH NEOPLASMS; TIME FACTORS;

ANIMALIA; MUS MUSCULUS;

EID: 33644996570     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1080/01926230600640058     Document Type: Article

References (31)

1. Adamson, R. H., Thorgeirsson, U. P., Snyderwine, E. G., Thorgeirsson, S. S., Reeves, J., Dalgard, D. W., Takayama, S., and Sugimura, T. (1990). Carcinogenicity of 2-amino-3-methylimidazo[4,5-f]quinoline in nonhuman primates: induction of tumors in three macaques. Jpn J Cancer Res 81, 10-4.
2. Dashwood, R. H. (2003). Use of transgenic and mutant animals models in the study of heterocyclic amine-induced mutagenicity and carcinogenesis. J Biochem Mol Biol 36, 35-42.
3. Goldfarb, S., Pugh, T. D., Koen, H., and He, Y. Z. (1983). Preneoplastic and neoplastic progression during hepatocarcinogenesis in mice injected with diethylnitrosamine in infancy. Environ Health Perspect 50, 149-61.
4. He, X. Y., Smith, G. J., Enno, A., and Nicholson, R. C. (1994). Short-term diethylnitrosamine-induced oval cell responses in three strains of mice. Pathology 26, 154-60.
5. Herzog, C. R., Schut, H. A., Maronpot, R. R., and You, M. (1993). ras mutations in 2-amino-3-methylimidazo-[4,5-f]quinoline-induced tumors in the CDF1 mouse. Mol Carcinog 8, 202-7.
6. International Agency for Research on Cancer (1993). IQ. In IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Some Naturally Occurring Substances: Food Items and Constituents, Heterocyclic Aromatic Amines and Mycotoxins, vol. 56, p. 165. IARC, Lyon, France.
7. Mitsumori, K., Koizumi, H., Nomura, T., and Yamamoto, S. (1998). Pathological features of spontaneous and induced tumors in transgenic mice carrying a human prototype c-Ha-ras gene used for six-month carcinogenicity studies. Toxicol Pathol 26, 520-31.
8. Morton, D., Alden, C. L., Roth, A. J., and Usui, T. (2002). The Tg rasH2 mouse in cancer hazard identification. Toxicol Pathol 30, 139-46.
9. Nagano, K., Katagiri, T., Aiso, S., Senoh, H., Sakura, Y., and Takeuchi, T. (1997). Spontaneous lesions of nasal cavity in aging F344 rats and BDF1 mice. Exp Toxicol Pathol 49, 97-104.
10. Nagao, M., Ushijima, T., Toyota, M., Inoue, R., and Sugimura, T. (1997). Genetic changes induced by heterocyclic amines. Mutat Res 376, 161-7.
11. Nerurkar, P. V., Anderson, L. M., Snyderwine, E. G., Park, S. S., Thorgeirsson, S. S., and Rice, J. M. (1993). Specific induction of hepatic cytochrome P4501a-2 in C57BL/6 and DBA/2 mice treated with 2-amino-3- methylimidazo[4,5-f]quinoline (IQ). J Biochem Toxicol 8, 175-86.
12. Ogawa, K., Masutani, M., Kato, K., Tang, M., Kamada, N., Suzuki, H., Nakagama, H., Sugimura, T., and Shirai, T. (2005). Parp-1 deficiency does not enhance liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5-f]quinoline in mice. Cancer Lett. in press.
13. Ohgaki, H., Kusama, K., Matsukura, N., Morino, K., Hasegawa, H., Sato, S., Takayama, S., and Sugimura, T. (1984). Carcinogenicity in mice of a mutagenic compound, 2-amino-3-methylimidazo[4,5-f]quinoline, from broiled sardine, cooked beef and beef extract. Carcinogenesis 5, 921-4.
14. Oinonen, T., and Lindros, K. O. (1998). Zonation of hepatic cytochrome P-450 expression and regulation. Biochem J 329 (Pt 1), 17-35.
15. Okamura, M., Moto, M., Kashida, Y., Machida, N., and Mitsumori, K. (2004a). Carcinogenic susceptibility to N-bis(2-hydroxypropyl)nitrosamine (DHPN) in rasH2 mice. Toxicol Pathol 32, 474-81.
16. Okamura, M., Sumida, K., Muto, T., Kashida, Y., Machida, N., Watanabe, T., and Mitsumori, K. (2004b). Analysis of gene expression profiles of forestomach tumors in rasH2 mice initiated with N-ethyl-N-nitrosourea. Arch Toxicol 78, 688-96.
17. Robinson, D. E., and MacDonald, J. S. (2001). Background and framework for ILSI's collaborative evaluation program on alternative models for carcinogenicity assessment. International Life Sciences Institute. Toxicol Pathol 29 Suppl, 13-9.
18. Saito, A., Kimura, M., Takahashi, R., Yokoyama, M., Nomura, T., Izawa, M., Sekiya, T., Nishimura, S., and Katsuki, M. (1990). Most tumors in transgenic mice with human c-Ha-ras gene contained somatically activated transgene. Oncogene 5, 1195-200.
19. Schut, H. A., and Snyderwine, E. G. (1999). DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis. Carcinogenesis 20, 353-68.
20. Sobol, R. W., Watson, D. E., Nakamura, J., Yakes, F. M., Hou, E., Horton, J. K., Ladapo, J., Van Houten, B., Swenberg, J. A., Tindall, K. R., Samson, L. D., and Wilson, S. H. (1999). Mutations associated with base excision repair deficiency and methylation-induced genotoxic stress. Proc Natl Acad Sci USA 99, 6860-65.
21. Sorensen, I. K., Mortensen, A., Kristiansen, E., van Kreijl, C., Adamson, R. H., and Thorgeirsson, S. S. (1996). Short-term carcinogenicity testing of 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine (PhIP) and 2-amino-3- methylimidazo[4,5-f]quinoline (IQ) in E(mu)-pim-1 transgenic mice. Carcinogenesis 17, 2221-7.
22. Suemizu, H., Muguruma, K., Maruyama, C., Tomisama, M., Kimura, M., Hioki, K., Shimozawa, N., Ohnishi, Y., Tamaoki. N., and Nomura, T. (2002). Transgene stability and features of rasH2 mice as an animal model for short-term Carcinogenicity testing. Mol Carcinog 34, 1-9.
23. Sugimura, T., Wakabayashi, K., Nakagama, H., and Nagao, M. (2004). Heterocyclic amines: Mutagens/carcinogens produced during cooking of meat and fish. Cancer Sci 95, 290-9.
24. Takayama, S., Nakatsuru, Y., Masuda, M., Ohgaki, H., Sato, S., and Sugimura, T. (1984). Demonstration of carcinogenicity in F344 rats of 2-amino-3-methyl-imidazo[4,5-f]quinoline from broiled sardine, fried beef and beef extract. Gann 75, 467-70.
25. Tamaoki, N. (2001). The rasH2 transgenic mouse: nature of the model and mechanistic studies on tumorigenesis. Toxicol Pathol 29 Suppl, 81-9.
26. Toyosawa, K., Tanaka, K., Imai, T., Yasuhara, K., Koujitani, T., Hirose, M., and Mitsumori, K. (2003). Mutation and overexpression of the transgene in ethylnitrosourea-induced tumors in mice carrying a human prototype c-Ha-ras gene. Toxicol Pathol 31, 491-5.
27. Tsuchiya, T., Kobayashi, K., Sakairi, T., Goto, K., Okada, M., Sano, F., Sugimoto, J., Morohashi, T., Usui, T., and Mutai, M. (2002). Skeletal myopathy in transgenic mice carrying human prototype c-Ha-ras gene. Toxicol Pathol 30, 501-6.
28. Tsuchiya, T., Okada, M., Sakairi, T., Sano, F., Sugimoto, J., and Takagi, S. (2005). Histopathological characterization of the skeletal myopathy in rasH2 mice carrying human prototype c-Ha-ras gene. J Vet Med Sci 67, 481-9.
29. Usui, T., Mutai, M., Hisada, S., Takaoka, M., Soper, K. A., McCullough, B., and Alden, C. (2001). CB6F1-rasH2 mouse: overview of available data. Toxicol Pathol 29 Suppl, 90-108.
30. Wu, R. W., Panteleakos, F. N., and Felton, J. S. (2003). Development and characterization of CHO repair-proficient cell lines for comparative mutagenicity and metabolism of heterocyclic amines from cooked food. Environ Mol Mutagen 41, 7-13.
31. Yamamoto, S., Mitsumori, K., Kodama, Y., Matsunuma, N., Manabe, S., Okamiya, H., Suzuki, H., Fukuda, T., Sakamaki, Y., Sunaga, M., Nomura, G., Hioki, K., Wakana, S., Nomura, T., and Hayashi, Y. (1996). Rapid induction of more malignant tumors by various genotoxic carcinogens in transgenic mice harboring a human prototype c-Ha-ras gene than in control non-transgenic mice. Carcinogenesis 17, 2455-61.